Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1986-08-08
1989-07-04
Brown, Johnnie R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
424 99, 424100, A61K 3702, A61K 3522
Patent
active
048450782
ABSTRACT:
A therapeutic agent for treating a hematopoietic disease containing, as an active ingredient, a glycoprotein which is recovered from human urine and acts upon the human bone marrow cells to stimulate the differentiation and proliferation of granulocytes-monocytes lineages thereof, or an active peptide fragment thereof or a derivative of said fragment, said therapeutic agent being administered after transplantation of the bone marrow.
REFERENCES:
patent: 3991182 (1976-11-01), Spitler et al.
patent: 4230697 (1980-10-01), Nishida et al.
patent: 4275056 (1981-06-01), Takaku et al.
patent: 4342828 (1982-08-01), Takaku et al.
patent: 4482485 (1984-11-01), Funakoshi et al.
patent: 4540574 (1985-09-01), Pierpaoli et al.
Wells et al., "Bone Marrow Transplantation", in Basic & Clinical Immunology, 5th Ed., Ch. 24, pp. 484-488, 1984.
Journal of chromatography, vol. 283, 1984, pp. 459-461, Elsevier Science Publishers, Amsterdam, NL; P. V. Byrne.
Chemical Abstracts, vol. 102, No. 3, Jan. 21, 1985, p. 487, Abst. No. 22216b.
Brown Johnnie R.
Green Cross Corporation
Morinaga Milk Industry Co. Ltd.
Stone Jacqueline M.
LandOfFree
Method for treating hematopoietic diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating hematopoietic diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating hematopoietic diseases will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-852476